176 A Randomized Controlled Trial of Rsv Prophylaxis with Motavizumab Vs Palivizumab in Young Children with Hemodynamically Significant Congenital Heart Disease
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.